Schizoaffective disorder is a psychotic disease with schizophrenic and affective i.e. depressive and/or manic symptoms. The disease can result in different patient outcomes depending upon the treatment applied. Patients suffering from the disease have in increased vulnerability towards stress and need an appropriate prophylactic medication so that they can perform social and maybe professional activities. Classical Neurotransmitters and Neuropeptides involved in Schizoaffective Disorder is a brief monograph that gives readers an overview of frequent psychotic diseases affecting patients. The contents of the monograph include details about biochemical alterations of classical neurotransmitters and neuropeptides in specific regions of the human brain, the susceptible genes and cellular mechanisms behind schizoaffective disorder, the neural networks of schizoaffective disorder and prophylactic pharmacotherapies administered to patients. Three case reports which demonstrate the alterations of classical neurotransmitters and neuropeptides in the brain are also presented. This monograph is a useful guide for medical residents and clinicians in training who wish to understand the basics about treating patients suffering from schizoaffective disorder.

March 19-21, 2018 | Berlin, Germany Key Topics : Drug Targeting and Design, Drug Delivery Technologies, Nanoparticulate Drug Delivery Systems, Pharmaceutical Nanotechnology, Nanomedicine and Nanotechnology, Smart Drug Delivery Systems, Biomaterials in Drug Delivery, Vaccine Drug Delivery Systems, Medical Devices for Drug Delivery, Peptides and Protein Drug Delivery, Green & Sustainable Pharma, 2D & 3D Printing in Drug Delivery, Pre-Formulation & Formulation Aspects, Pharmacokinetics and Pharmacodynamics in drugs, Routes of Drug Delivery, Nanotechnology in Drug Delivery, Global Drug Delivery Policy, Biomedicine and Pharmacotherapy,

Schizophrenia and Psychotic Spectrum Disorders aims to engage young caregivers in psychiatry, psychology, nursing and social work so that they will be able to become well informed about this significant--and at times confusing--illness. Because schizophrenia is considered to be one of the most complicated and severe psychiatric disorders, this book has the goal of summarizing key issues of the illness, such as its presentation, frequency and age of onset, and diagnostic characteristics. It also contains informative chapters about the pathophysiology of schizophrenia, ranging from brain development issues, genetics, and likely abnormalities in neurotransmitters. This book will give young professionals and those joining the field an excellent and accessible background to treatment. In this area, Schizophrenia and Psychotic Spectrum Disorders provides a comprehensive approach to diagnosis, treatment initiation, strategies for non-response, approaches of therapy, and importantly, ways to provide family therapy and support.

A versatile reference text for developing and applying clinical psychopathology skills Designed to serve as a trusted desktop reference on mental disorders seen across the lifespan for mental health professionals at all levels of experience, Diagnosis and Treatment of Mental Disorders Across the Lifespan, Second Edition expertly covers etiology, clinical presentation, intake and interviewing, diagnosis, and treatment of a wide range of DSM disorders at all developmental stages. Unlike other references, this book takes a lifespan approach that allows readers to develop the clinical skills necessary to respond to mental health concerns in a patient-centered manner. Introductory and advanced features support clinicians at every stage of their careers and help students develop their skills and understanding. Authors Woo and Keatinge combine a review of cutting edge and state-of-the-art findings on diagnosis and treatment with the tools for diagnosing and treating a wide range of mental disorders across the lifespan. . This second edition incorporates the following changes: Fully updated to reflect the DSM-5 Chapters have been reorganized to more closely follow the structure of the DSM-5 Cultural and diversity considerations have been expanded and integrated throughout the book A new integrative model for treatment planning Expanded discussion of rapport building skills and facilitating active engagement Identity issues and the fit between client and intervention model has been added to the case conceptualization model Mental health disorders affect patients of all ages, and the skilled clinician understands that there are no one-size-fits-all treatments. Diagnosis and Treatment of Mental Disorders Across the Lifespan, Second Edition will instruct clinicians and students in psychopathology for every life stage. Praise for the first edition: Reviews This handbook, Diagnosis and Treatment of Mental Disorders Across the Lifespan, comprehensively integrates best practices necessary for clinicians who deal with a wide range of mental disorders across the continuum of development in a practical, applied, and accessible manner. One of the unique aspects of the book is the length to which the authors go to ensure that the up-to-date information contained in the book is practical, user-friendly, and accessible to beginners in clinical practice

The single most readily readable source of information on psychopharmacology, covering disease and drug mechanisms in one highly illustrated volume.

Clinical staging is a solution to transform psychiatric diagnosis and improve mental health outcomes.

The diagnosis of mental illness is frequently accompanied by sleep problems; conversely, people experiencing sleep problems may subsequently develop mental illness. Sleep and Mental Illness looks at this close correlation and considers the implications of research findings that have emerged in the last few years. Additionally, it surveys the essential concepts and practical tools required to deal with sleep and co-morbid psychiatric problems. The volume is divided into three main sections: basic science, neuroendocrinology, and clinical science. Included are over 30 chapters on topics such as neuropharmacology, insomnia, depression, dementia, autism, and schizophrenia. Relevant questionnaires for the assessment of sleep disorders, including quality-of-life measurement tools, are provided. There is also a summary table of drugs for treating sleep disorders. This interdisciplinary text will be of interest to clinicians working in psychiatry, behavioral sleep medicine, neurology, pulmonary and critical care medicine.

"The 2nd edition of this book was edited by David King and published in 2004. Since then there have been major advances in psychopharmacology in terms of new medications coming to the market, increased understanding of the mechanisms of drug action and new data on the efficacy, tolerability, safety and clinical effectiveness of a range of medications. Partly as a result, clinical guidelines for many psychiatric disorders have altered. As such, a new edition of this textbook was essential and we were delighted when the College approached us to edit the 3rd edition. This was a major endeavor that was only possible with the commitment and expertise of the authors"--

Despite considerable progress in clinical and basic neurosciences, the cure of psychiatric disorders is still remote, little is known about their prevention, and the etiology and molecular mechanisms of mental disorders are still obscure. Diagnoses are still guided by patients' stories. The mission of animal models is to bridge the gap between `the story and the synapse.' Contemporary Issues in Modeling of Psychopathology attempts to do this by examining such questions as `What good might come from such a model? Are we wasting our time? How far can we carry results from model animals, such as rats and mice, without causing a highly distorted view of the field and its goals?' This book serves as the opening volume for a new series, Neurobiological Foundation of Aberrant Behaviors.